Natixis Advisors, L.P. Charles River Laboratories International, Inc. Transaction History
Natixis Advisors, L.P.
- $53.5 Billion
- Q4 2024
A detailed history of Natixis Advisors, L.P. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 78,439 shares of CRL stock, worth $12.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
78,439
Previous 84,143
6.78%
Holding current value
$12.1 Million
Previous $16.6 Million
12.63%
% of portfolio
0.03%
Previous 0.03%
Shares
30 transactions
Others Institutions Holding CRL
# of Institutions
699Shares Held
51.6MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.16MShares$948 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$784 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$628 Million0.14% of portfolio
-
State Street Corp Boston, MA2.13MShares$328 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$299 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.83B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...